Alaunos Therapeutics TCRT
NASDAQ TCRT
$0.90 +0.01 (+1.41%)
As of: Oct 1, 2026 · 2:32 PM EDT

Alaunos Therapeutics (TCRT) EV to CFO (2015)

Updated

Alaunos Therapeutics' (TCRT) EV to CFO came in at 72.94 for Q3 2015.

Analysis

Alaunos Therapeutics (TCRT) EV to CFO (2015) Analysis & Trends

For the trailing twelve months through Sep 30, 2015, EV to CFO at Alaunos Therapeutics was 52.04.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Alaunos Therapeutics 2.19 Mn -1.61 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2015 72.94
API Access

Alaunos Therapeutics EV to CFO API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-cfo&ticker=TCRT&period=max&api_key=YOUR_API_KEY